ArticleScientific reports2025
Enhanced THBS2 promotes collagen synthesis and inflammatory secretome of fibroblasts in idiopathic pulmonary fibrosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Formononetin ameliorates bleomycin-induced pulmonary fibrosis in mice via targeting USP5.Journal of thoracic disease · 2026Article
- Review
- Proteomic study of high-altitude pulmonary hypertension in the Xinjiang Pamir highlanders.BMC pulmonary medicine · 2026Article
- Spatial Distribution of K13-Positive Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis.Biomedicines · 2026Article
- The Role of Thrombospondin-2 in Myocardial Fibrosis.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of pulmonary fibrosis involves structural remodeling and functional impairment of lung tissue, accompanied by increased secretion of pro-inflammatory mediators and abnormal synthesis of the extracellular matrix (ECM). Thrombospondin-2 (THBS2), an ECM glycoprotein encoding gene, has been extensively studied in liver and heart fibrosis. However, its role in idiopathic pulmonary fibrosis (IPF) in humans remains incompletely understood. Lung fibroblasts were obtained from normal individuals and IPF patients, and THBS2 expression was detected. Then, THBS2 overexpression and knockdown cell models as well as exogenous human THBS2 active protein administration cell models were established to explore the role of THBS2 in cell aggressive phenotype, collagen synthesis and proinflammatory mediator secretion. Furthermore, TGF-β1 inhibitor was used to investigate the underlying mechanism of THBS2 affecting collagen synthesis. Finally, in the bleomycin (BLM) -induced pulmonary fibrosis model, the severity of pulmonary fibrosis in mice was evaluated by administering exogenous mouse THBS2 active protein. THBS2 expression was significantly up-regulated in lung tissues of IPF patients and in IPF lung fibroblasts. THBS2 Overexpression and exogenous human THBS2 active protein markedly enhanced the proliferation and migration of fibroblasts and increased the levels of COL1A1, COL1A2, COL3A1, LOX and LOXL2. These effects were attenuated after knockdown of THBS2 in IPF fibroblasts. Animal models also confirmed that exogenous mouse THBS2 protein could aggravate bleomycin-induced pathological changes and collagen deposition in lung tissues of mice. Using TGF-β1 inhibitor SB525334 reduced the protein expression of downstream molecules (TGFBR1, TGFBR2, P-Smad2/3) and collagen synthesis but did not inhibit the upregulation of post-translational modification enzymes LOX and LOXL2 involved in collagen synthesis. Meanwhile, we observed that THBS2 overexpression significantly promoted inflammatory secretome (IL-1β, IL-6 and IL-8). THBS2 is overexpressed in IPF. Functionally, THBS2 promotes the invasive phenotype (proliferation and migration), collagen synthesis and inflammation secretome in fibroblasts. Mechanistically, THBS2 promotes collagen synthesis through the TGF-β1/Smad2/3 signaling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.